This model is supported by some human studies, such as those of multiple groups finding high levels of alpha-synuclein pathology in skin biopsies in early PD and REM-sleep behavior disorder (RBD) without other clinical evidence of synucleinopathy (12, 25, 26, 77–79). The gene discussed is SNCA; the disease is synucleinopathy.